A young mother has died from cervical cancer after being classed as too young for a smear test…

The American College of Physicians (ACP) today released clinical advice aimed at reducing overuse of cervical cancer screening in average risk women without…

New research out of Queen’s University shows early benefits from the human papillomavirus (HPV) vaccine in young girls.

The HPV vaccine, which protects against four types of HPV shown to cause…

It’s a virus that is responsible for almost all cases of cervical cancer but a new study by University of Texas Medical Branch…

Research presented at the 29th Annual International Papillomavirus Conference shows that a therapy being developed by Hera Therapeutics Inc. combats three types of human…

A study published online in the International Journal of Cancer earlier this month describes a novel approach to preventing cervical cancer based on findings showing successful reduction in the risk…

A new type of personalized cancer therapy in which immune cells are harvested from patients’ tumors, grown in the lab and infused back into patients showed dramatic results in…

Cervical cancer rates in the United States are higher than previously believed, particularly among 65- to 69-year-old women and African-American women, according to a study…

Rates of cervical cancer in American women may be higher than previously thought, and the disease may arise most often at an age when adequately screened…

It’s long been known that certain strains of human papillomavirus (HPV) cause cancer. Now, researchers at The Ohio State University have determined a new way that HPV might…

U.S. health experts recommended that a test for cancer-causing strains of the human papillomavirus (HPV) be approved to replace Pap smears in screening most women for…

A new clinical study has found that erlotinib, a targeted antitumor agent, has promising potential to improve treatment for cervical cancer. Published early online in CANCER, a…

Research on cervical cancer performed by a physician at the University of Arizona Cancer Center at St. Joseph’s Hospital and Medical Center has been published in the New England Journal of Medicine. The…

The risk of developing cervical cancer can be significantly decreased through human papillomavirus (HPV) vaccination.  Despite calls from leading health and professional organizations for…

Researchers from the Boston area, Mexico, and Norway have completed a comprehensive genomic analysis of cervical cancer in two patient populations. The study identified recurrent genetic mutations not…

Knowledge about the efficacy of the human papillomavirus (HPV) vaccine in preventing cervical cancer was lacking in the majority of survey respondents for whom the information would be relevant, according to…

A study by Indiana University public health researchers found that the opportunity for significant progress in addressing cervical cancer across the country is being squandered…

Women vaccinated with one dose of a human papillomavirus (HPV) vaccine had antibodies against the viruses that remained stable in their blood for four years,…

Initiation and completion rates for the human papillomavirus vaccine series are significantly lower in the South than any other geographic region, according to a new study…

In a large study of nearly a million girls in Denmark and Sweden, the human papillomavirus vaccine was not linked to short- or long-term health problems.

The HPV vaccine, given in…

A Mayo Clinic physician and two other pediatric experts say that parental perceptions pose a major barrier to acceptance of human papillomavirus (HPV) vaccination - and that many of those…

A study by researchers at Brigham and Women’s Hospital (BWH) found that brachytherapy treatment was associated with better cause-specific survival and overall survival in…

A new study has revealed marked differences in the genomic terrain of the two most common types of cervical cancer, suggesting that patients might benefit from therapies geared…

Recent breakthroughs in cervical cancer prevention have resulted in new vaccination and cervical cancer screening guidelines. Recommendations do not always translate into practice, however. Less than…

Doctors at Washington University School of Medicine in St. Louis have shown that testing cervical tumors before treatment for vulnerability to chemotherapy predicts whether patients will do well or poorly with…